Merck buys controlling stake in Physicians Interactive

Share this article:

Merck's Global Health Innovation Fund (GHIF) has taken a controlling interest in digital physician marketing firm Physicians Interactive, MM&M has learned. Financial terms of the deal were not disclosed.

The takeover of Marlborough, MA-based Physician's Interactive, which provides online and mobile clinical tools and marketing to doctors like e-sampling and interactive education programs, follows a $17-million stake taken by GHIF in January 2012.

By expanding its stake in PI, Merck is deepening its relationship with a well-established provider of non-personal promotion to HCPs, a commodity in this era when drug makers are fielding much slimmer sales forces.

“PI offers low-cost, multi-channel, integrated marketing solutions and applications, generated from its online platform of user-generated, proprietary and public data, to enable medical professionals to deliver better patient care,” said Merck in a statement. “These programs can be used to supplement currently promoted products as well as non-promoted and orphaned products that still have value to physicians and patients.”

“PI will operate independently and maintain its own governance, policies and corporate IT infrastructure to ensure the security of its customers' data and intellectual property,” Merck added.

The previous majority owner of PI was private equity firm Perseus Capital.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.